The effect of a new oral anticoagulant (Rivaroxaban) on implants pull-out strength. An experimental study in rats.

Kapetanou, Artemis G; Savvidis, Matthaios S; Potoupnis, Michael E; Petsatodis, George E; Kirkos, John M; Kapetanos, George A

Kapetanou, Artemis G; Savvidis, Matthaios S; Potoupnis, Michael E; Petsatodis, George E; Kirkos, John M; Kapetanos, George A.

Affiliation

Kapetanou AG; Orthopaedic Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Savvidis MS; Orthopaedic Department, 424 Military Hospital, Thessaloniki, Greece.
Potoupnis ME; Orthopaedic Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Petsatodis GE; Orthopaedic Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Kirkos JM; Orthopaedic Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Kapetanos GA; Orthopaedic Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.

J Frailty Sarcopenia Falls ; 2(1): 1-5, 2017 Mar.

Article de En | MEDLINE | ID: mdl-32300674

Mots clés

Anticoagulation; Oral; Osseointegration; Pull-out; Rivaroxaban

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: J Frailty Sarcopenia Falls Année: 2017 Type de document: Article Pays d'affiliation: Grèce Pays de publication: Grèce

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google